APAF Newsletter Vol. 8 No. 1

APAF Newsletter Vol. 8 No. 1

APAF and its’ staff would like to wish you all the best for a successful 2018 and thank you for your continued support throughout 2017. In this newsletter we highlight two case studies where APAF partnered with Industry to address key biological problems using proteomics. We also shine the spotlight on collaborative research with Dr Albert Lee and colleagues from Macquarie University using phosphoproteomics to investigate the novel role of CCNF in the debilitating neurodegenerative disease of amyotrophic lateral sclerosis.

With grant season upon us, we welcome your enquires as collaborative partners or contractors for proteomic analyses.

Enhancing chicken meat production with nutrient feedstocks variations.

Enhancing chicken meat production with nutrient feedstocks variations

There is great desire to make savings in feedstock costs while maintaining and enhancing meat production. In this project, APAF partnered with Feedworks P/L, a major supplier of agricultural feed products to examine different feed variations versus the production output and different measures of important metabolic parameters such as amino acids and glucose. Read more.

APAF partners with Sugar Research Australia to characterise Yellow Canopy Syndrome in sugarcane

APAF partners with Sugar Research Australia to characterise Yellow Canopy Syndrome in sugarcane

Yellow Canopy Syndrome (YCS) was first observed in 2012 in Far North Queensland, and it has been confirmed in cane-growing regions from the Wide Bay north. Since then, there has been a concerted effort by Sugar Research Australia (SRA) to understand the cause – and management – of this mysterious syndrome.

Researchers have analysed the sugarcane genome and can rule out a group of viruses that hide within the DNA and later emerge to cause disease. Read more

Phosphoregulation of a novel cyclin (CCNF) associated with Amyotropic lateral sclerosis

Phosphoregulation of a novel cyclin (CCNF) associated with Amyotropic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are fatal neurodegenerative disorders that have common and convergent molecular and pathogenic features. Read more

Back to the top of this page